Therapeutic compounds

Details for Australian Patent Application No. 2009279936 (hide)

Owner Merck Sharp & Dohme Corp. Banyu Pharmaceutical Co., Ltd.

Inventors Katz, Jason; Jewell, James; Jung, Joon; Kattar, Solomon; Hou, Yongquan; Maccoss, Rachel; Ito, Satoru

Agent Spruson & Ferguson

Pub. Number AU-A-2009279936

PCT Pub. Number WO2010/017047

Priority 61/137,979 05.08.08 US

Filing date 27 July 2009

Wipo publication date 11 February 2010

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/017047 Priority application(s): WO2010/017047

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Banyu Pharmaceutical Co., Ltd.; Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279937-Substituted dihydroisoquinolinone and isoquinolinedione derivatives as calcium channel blockers

2009279927-Remote call control for mobile telecommunication devices and services